Bower Marlee, Smout Scarlett, Donohoe-Bales Amarina, O'Dean Siobhan, Teesson Lily, Boyle Julia, Lim Denise, Nguyen Andre, Calear Alison L, Batterham Philip J, Gournay Kevin, Teesson Maree
The Matilda Centre for Research in Mental Health and Substance Use, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Centre for Mental Health Research, The Australian National University, Canberra, ACT, Australia.
Front Psychiatry. 2023 Mar 8;14:1107560. doi: 10.3389/fpsyt.2023.1107560. eCollection 2023.
The mental health impacts of the COVID-19 pandemic remain a public health concern. High quality synthesis of extensive global literature is needed to quantify this impact and identify factors associated with adverse outcomes.
We conducted a rigorous umbrella review with meta-review and present (a) pooled prevalence of probable depression, anxiety, stress, psychological distress, and post-traumatic stress, (b) standardised mean difference in probable depression and anxiety pre-versus-during the pandemic period, and (c) comprehensive narrative synthesis of factors associated with poorer outcomes. Databases searched included Scopus, Embase, PsycINFO, and MEDLINE dated to March 2022. Eligibility criteria included systematic reviews and/or meta-analyses, published post-November 2019, reporting data in English on mental health outcomes during the COVID-19 pandemic.
Three hundred and thirty-eight systematic reviews were included, 158 of which incorporated meta-analyses. Meta-review prevalence of anxiety symptoms ranged from 24.4% (95%CI: 18-31%, : 99.98%) for general populations to 41.1% (95%CI: 23-61%, : 99.65%) in vulnerable populations. Prevalence of depressive symptoms ranged from 22.9% (95%CI: 17-30%, : 99.99%) for general populations to 32.5% (95%CI: 17-52%, : 99.35) in vulnerable populations. Prevalence of stress, psychological distress and PTSD/PTSS symptoms were 39.1% (95%CI: 34-44%; : 99.91%), 44.2% (95%CI: 32-58%; : 99.95%), and 18.8% (95%CI: 15-23%; : 99.87%), respectively. Meta-review comparing pre-COVID-19 to during COVID-19 prevalence of probable depression and probable anxiety revealed standard mean differences of 0.20 (95%CI = 0.07-0.33) and 0.29 (95%CI = 0.12-0.45), respectively.
This is the first meta-review to synthesise the longitudinal mental health impacts of the pandemic. Findings show that probable depression and anxiety were significantly higher than pre-COVID-19, and provide some evidence that that adolescents, pregnant and postpartum people, and those hospitalised with COVID-19 experienced heightened adverse mental health. Policymakers can modify future pandemic responses accordingly to mitigate the impact of such measures on public mental health.
2019年冠状病毒病(COVID-19)大流行对心理健康的影响仍是一个公共卫生问题。需要高质量地综合大量全球文献,以量化这种影响并确定与不良后果相关的因素。
我们进行了一项严格的伞状综述和元综述,呈现(a)可能的抑郁、焦虑、压力、心理困扰和创伤后应激障碍的合并患病率,(b)大流行期间与大流行前相比可能的抑郁和焦虑的标准化平均差异,以及(c)与较差结果相关因素的全面叙述性综合。检索的数据库包括截至2022年3月的Scopus、Embase、PsycINFO和MEDLINE。纳入标准包括2019年11月后发表的系统综述和/或元分析,以英文报告COVID-19大流行期间心理健康结果的数据。
纳入了338项系统综述,其中158项纳入了元分析。元综述中焦虑症状的患病率在普通人群中为24.4%(95%置信区间:18 - 31%,I²:99.98%),在弱势群体中为41.1%(95%置信区间:23 - 61%,I²:99.65%)。抑郁症状的患病率在普通人群中为22.9%(95%置信区间:17 - 30%,I²:99.99%),在弱势群体中为32.5%(95%置信区间:17 - 52%,I²:99.35%)。压力、心理困扰和创伤后应激障碍/创伤后应激症状的患病率分别为39.1%(95%置信区间:34 - 44%;I²:99.91%)、44.2%(95%置信区间:32 - 58%;I²:99.95%)和18.8%(95%置信区间:15 - 23%;I²:99.87%)。比较COVID-19前与COVID-19期间可能的抑郁和可能的焦虑患病率的元综述显示标准化平均差异分别为0.20(95%置信区间 = 0.07 - 0.33)和0.29(95%置信区间 = 0.12 - 0.45)。
这是第一项综合该大流行对心理健康纵向影响的元综述。研究结果表明,可能的抑郁和焦虑显著高于COVID-19前,并提供了一些证据表明青少年、孕妇和产后人群以及COVID-19住院患者经历了更严重的不良心理健康状况。政策制定者可以相应地调整未来的大流行应对措施,以减轻此类措施对公众心理健康的影响。